Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis

Hepatology Research

Volumn 39, Issue 1, 2009, Pages 31-39

  Kobayashi, Minoru ^a   Suzuki, Michihiro ^a   Ikeda, Hiroki ^a   Takahashi, Hideaki ^a   Matsumoto, Nobuyuki ^a   Maeyama, Shiro ^a,b   Sase, Shigeru ^c   Iino, Shiro ^d   Itoh, Fumio ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kitakashiwa Rehabilitation Hospital   (Japan)

^c Anzai Medical   (Japan)

^d Kiyokawa Hospital   (Japan)

Author keywords

Lambda value; NASH; Tissue blood flow; Xenon computed tomography

Indexed keywords

XENON;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER BIOPSY; LIVER BLOOD FLOW; LIVER FIBROSIS; MALE; NON INVASIVE MEASUREMENT; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLUBILITY;

EID: 58149200955     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00407.x     Document Type: Article

References (32)

1. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis 1986; 8: 283-98.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
3. Hashimoto E, Yatsuji S, Kaneda H et al. The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease. Hepatol Res 2005; 33: 72-6.
4. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-19.
5. Marrero JA, Fontana RJ, Su GL, Conieevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002; 36: 1349-54.
6. Adams LA, Lymp JF, St Sauver J et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005; 129: 113-21.
7. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 1649-57.
8. American Gastroenterological Association. AGA technical review on Nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-25.
9. Wanless IR, Lents JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-10.
10. Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in Nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50.
11. Gur D, Good WF, Wolfson SK, Shabason L. In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography. Science 1982; 215: 1267-8.
12. Johnson DW, Stringer WA, Marks MP, Yonas H, Good WF, Gur D. Stable xenon CT cerebral blood flow imaging: Rationale for and role in clinical decision making. Am J Neuroradiol 1991; 12: 201-13.
13. Sase S, Monden M, Oka H, Dono K, Fukuta T, Shibata I. Hepatic blood flow measurements with arterial and portal blood flow mapping in the human liver by means of xenon CT. J Comput Assist Tomogr 2002; 26: 243-9.
14. Ikeda H, Suzuki M, Kobayashi M et al. Xenon computed tomography shows hemodynamic change during the progression of chronic hepatitis C. Hepatol Res 2007; 37: 104-12.
15. Sase S, Suzuki M, Ikeda H et al. Quantitative multilevel mapping of hepatic blood flow by xenon computed tomography using aorta. J Comput Assist Tomogr 2003; 27: 647-51.
16. Andersen AM, Ladefoged J. Partition coefficient of 133-xenon between various tissues and blood in vivo. Scand J Clin Lab Invest 1967; 19: 72-8.
17. Steward A, Allot PR, Cowles AL, Maepleson WW. Solubility coefficients for inhaled anaesthetics for water, oil and biological media. Br J Anaesth 1973; 45: 282-93.
18. Brunt EM, Janney CG, di Bisceglie AM, NeuschwanderTetri BA, Bacon BR. Non-alcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
19. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult: Its usefulness in predicting the presence of diffuse liver disease. Radiology 1980; 137: 727-9.
20. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo clinic experiences with hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
21. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow up study of forty-two patients for 21 years. Hepatology 1990; 11: 74-80.
22. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-19.
23. Ratziu V, Charlotte F, Heurtier A et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-906.
24. Merriman RB, Ferrell LD, Patti MG et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006; 44: 874-80.
25. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993; 188: 405-11.
26. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: Dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001; 176: 667-73.
27. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: Correlations with degree of cirrhosis and portal hypertension. Radiology 2003; 229: 409-14.
28. Richter S, Mücke I, Menger MD, Vollmar B. Impact of intrinsic blood flow regulation in cirrhosis: Maintenance of hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol 2000; 279: G454-62.
29. Gülberg V, Haag K, Rössle M, Gerbes AL. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 2002; 35: 630-4.
30. Takahashi H, Suzuki M, Ikeda H et al. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis: Comparison with liver cirrhosis C. Alcohol Clin Exp Res 2007; 31: S43-8.
31. Ijaz S, Yang W, Winslet MC, Seifalian AM. Impairment of hepatic microcirculation in fatty liver. Microcirculation 2003; 10: 447-56.
32. Ong J, Younossi ZM, Reddy V, Price LL, Mayes J, Boparai N. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl 2001; 7: 797-801.